Cargando…

Increased Maternal Prenatal Adiposity, Inflammation, and Lower Omega-3 Fatty Acid Levels Influence Child Negative Affect

OBJECTIVE: Increased maternal adiposity during pregnancy is associated with offspring risk for psychiatric disorders. Inflammation secondary to adiposity is believed to be an important mechanism through which this effect occurs. Although increased adiposity introduces risk, not all children of overw...

Descripción completa

Detalles Bibliográficos
Autores principales: Gustafsson, Hanna C., Holton, Kathleen F., Anderson, Ashley N., Nousen, Elizabeth K., Sullivan, Ceri A., Loftis, Jennifer M., Nigg, Joel T., Sullivan, Elinor L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779776/
https://www.ncbi.nlm.nih.gov/pubmed/31632234
http://dx.doi.org/10.3389/fnins.2019.01035
_version_ 1783456969345990656
author Gustafsson, Hanna C.
Holton, Kathleen F.
Anderson, Ashley N.
Nousen, Elizabeth K.
Sullivan, Ceri A.
Loftis, Jennifer M.
Nigg, Joel T.
Sullivan, Elinor L.
author_facet Gustafsson, Hanna C.
Holton, Kathleen F.
Anderson, Ashley N.
Nousen, Elizabeth K.
Sullivan, Ceri A.
Loftis, Jennifer M.
Nigg, Joel T.
Sullivan, Elinor L.
author_sort Gustafsson, Hanna C.
collection PubMed
description OBJECTIVE: Increased maternal adiposity during pregnancy is associated with offspring risk for psychiatric disorders. Inflammation secondary to adiposity is believed to be an important mechanism through which this effect occurs. Although increased adiposity introduces risk, not all children of overweight mothers develop these problems. Gestational factors that modify this risk are not well-understood. If maternal increased adiposity exerts its effects on offspring outcomes by increasing inflammation in the gestational environment, then anti-inflammatory inputs such as omega-3 fatty acids may be one protective factor. The goal of this study was to investigate whether maternal pre-pregnancy body mass index (BMI) and omega-3 fatty acid levels independently and/or interactively predicted offspring infant negative affect, an early life marker of risk for psychopathology. METHODS: Data came from a prospective study of women recruited during pregnancy and their 6 month old infants (N = 62; 40% female). Maternal pre-pregnancy BMI was pulled from medical charts and third trimester omega-3 fatty acid concentrations were assessed in plasma. Child negative affect was assessed using observer- and maternal-ratings at 6 months of age. Maternal inflammation was indexed by third trimester plasma levels of interleukin-6, tumor necrosis factor-alpha, and monocyte chemoattractant protein-1. RESULTS: Maternal pre-pregnancy BMI was associated with increased infant negative affect whereas eicosapentaenoic acid was associated with less infant negative affect. Maternal omega-3 fatty acid levels moderated the effect of BMI on infant negative affect, such that omega-3 fatty acids buffered children against the negative consequences of increased adiposity. Supporting the role of maternal inflammation in these associations, maternal BMI and omega-3 fatty acid levels interacted to predict maternal third trimester inflammation. Further, maternal inflammation was associated with increased infant negative affect. CONCLUSION: Results suggest that omega-3 supplementation during pregnancy may protect against offspring behavioral risk associated with increased maternal adiposity.
format Online
Article
Text
id pubmed-6779776
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67797762019-10-18 Increased Maternal Prenatal Adiposity, Inflammation, and Lower Omega-3 Fatty Acid Levels Influence Child Negative Affect Gustafsson, Hanna C. Holton, Kathleen F. Anderson, Ashley N. Nousen, Elizabeth K. Sullivan, Ceri A. Loftis, Jennifer M. Nigg, Joel T. Sullivan, Elinor L. Front Neurosci Neuroscience OBJECTIVE: Increased maternal adiposity during pregnancy is associated with offspring risk for psychiatric disorders. Inflammation secondary to adiposity is believed to be an important mechanism through which this effect occurs. Although increased adiposity introduces risk, not all children of overweight mothers develop these problems. Gestational factors that modify this risk are not well-understood. If maternal increased adiposity exerts its effects on offspring outcomes by increasing inflammation in the gestational environment, then anti-inflammatory inputs such as omega-3 fatty acids may be one protective factor. The goal of this study was to investigate whether maternal pre-pregnancy body mass index (BMI) and omega-3 fatty acid levels independently and/or interactively predicted offspring infant negative affect, an early life marker of risk for psychopathology. METHODS: Data came from a prospective study of women recruited during pregnancy and their 6 month old infants (N = 62; 40% female). Maternal pre-pregnancy BMI was pulled from medical charts and third trimester omega-3 fatty acid concentrations were assessed in plasma. Child negative affect was assessed using observer- and maternal-ratings at 6 months of age. Maternal inflammation was indexed by third trimester plasma levels of interleukin-6, tumor necrosis factor-alpha, and monocyte chemoattractant protein-1. RESULTS: Maternal pre-pregnancy BMI was associated with increased infant negative affect whereas eicosapentaenoic acid was associated with less infant negative affect. Maternal omega-3 fatty acid levels moderated the effect of BMI on infant negative affect, such that omega-3 fatty acids buffered children against the negative consequences of increased adiposity. Supporting the role of maternal inflammation in these associations, maternal BMI and omega-3 fatty acid levels interacted to predict maternal third trimester inflammation. Further, maternal inflammation was associated with increased infant negative affect. CONCLUSION: Results suggest that omega-3 supplementation during pregnancy may protect against offspring behavioral risk associated with increased maternal adiposity. Frontiers Media S.A. 2019-10-01 /pmc/articles/PMC6779776/ /pubmed/31632234 http://dx.doi.org/10.3389/fnins.2019.01035 Text en Copyright © 2019 Gustafsson, Holton, Anderson, Nousen, Sullivan, Loftis, Nigg and Sullivan. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Gustafsson, Hanna C.
Holton, Kathleen F.
Anderson, Ashley N.
Nousen, Elizabeth K.
Sullivan, Ceri A.
Loftis, Jennifer M.
Nigg, Joel T.
Sullivan, Elinor L.
Increased Maternal Prenatal Adiposity, Inflammation, and Lower Omega-3 Fatty Acid Levels Influence Child Negative Affect
title Increased Maternal Prenatal Adiposity, Inflammation, and Lower Omega-3 Fatty Acid Levels Influence Child Negative Affect
title_full Increased Maternal Prenatal Adiposity, Inflammation, and Lower Omega-3 Fatty Acid Levels Influence Child Negative Affect
title_fullStr Increased Maternal Prenatal Adiposity, Inflammation, and Lower Omega-3 Fatty Acid Levels Influence Child Negative Affect
title_full_unstemmed Increased Maternal Prenatal Adiposity, Inflammation, and Lower Omega-3 Fatty Acid Levels Influence Child Negative Affect
title_short Increased Maternal Prenatal Adiposity, Inflammation, and Lower Omega-3 Fatty Acid Levels Influence Child Negative Affect
title_sort increased maternal prenatal adiposity, inflammation, and lower omega-3 fatty acid levels influence child negative affect
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779776/
https://www.ncbi.nlm.nih.gov/pubmed/31632234
http://dx.doi.org/10.3389/fnins.2019.01035
work_keys_str_mv AT gustafssonhannac increasedmaternalprenataladiposityinflammationandloweromega3fattyacidlevelsinfluencechildnegativeaffect
AT holtonkathleenf increasedmaternalprenataladiposityinflammationandloweromega3fattyacidlevelsinfluencechildnegativeaffect
AT andersonashleyn increasedmaternalprenataladiposityinflammationandloweromega3fattyacidlevelsinfluencechildnegativeaffect
AT nousenelizabethk increasedmaternalprenataladiposityinflammationandloweromega3fattyacidlevelsinfluencechildnegativeaffect
AT sullivanceria increasedmaternalprenataladiposityinflammationandloweromega3fattyacidlevelsinfluencechildnegativeaffect
AT loftisjenniferm increasedmaternalprenataladiposityinflammationandloweromega3fattyacidlevelsinfluencechildnegativeaffect
AT niggjoelt increasedmaternalprenataladiposityinflammationandloweromega3fattyacidlevelsinfluencechildnegativeaffect
AT sullivanelinorl increasedmaternalprenataladiposityinflammationandloweromega3fattyacidlevelsinfluencechildnegativeaffect